Clinical Evaluation of Flortaucipir F 18

Summary

This study is designed to expand the database of flortaucipir F 18 safety and tau binding as measured by PET imaging and to provide standardized conditions for flortaucipir PET use, data collection and analysis to facilitate companion studies including, but not limited to, longitudinal studies of aging, depression, and traumatic brain injury.

Timeline

Start

2014-12

Primary completion

2019-06-26

Completion

2019-06-26

Drugs

Indications